Meeting
2023 ASCO Annual Meeting
The performance of prostate specific antigen (PSA) testing in the population based NPCC cohort.
Authors
Jan Oldenburg
Department of Oncology, Akershus University Hospital (Ahus), Lørenskog, Norway
Jan Oldenburg , Johan Lars Bjerner , Lara Pasovic , Stig Müller , Sophie D. Fossa , Sigrid V. Carlsson , Peter C. Albertsen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 5029)
DOI
10.1200/JCO.2023.41.16_suppl.5029
Abstract #
5029
Poster Bd #
123
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Rapid quantification of prostate specific antigen (PSA) from fingerstick (FS) blood.
First Author: Joseph Earl Thomas
Poster
2023 ASCO Genitourinary Cancers Symposium
Disparities in prostate cancer diagnoses in persons experiencing homelessness.
First Author: Zachary S Mayo
Poster
2022 ASCO Annual Meeting
Methylated DNA markers in urine aid in the selective identification of patients with prostate cancer as well as clinically significant pathology.
First Author: Paras Shah
Poster
2022 ASCO Genitourinary Cancers Symposium
Impact of U.S. Preventative Services Task Force grade D recommendation against prostate-specific antigen screening on prostate cancer mortality.
First Author: Laura Burgess